| Literature DB >> 33937111 |
Diego Rocco1, Vincenzo Calvo2, Vito Agrosi3, Francesca Bergami3, Luce Maria Busetto3, Silvia Marin3, Giovanna Pezzetta3, Luca Rossi3, Lorenzo Zuccotti3, Allan Abbass4.
Abstract
This study examines the effectiveness of psychotherapy provided by novice therapists, in an attempt to clarify the controversial relationship between treatment effectiveness and therapist experience. To achieve this, we examined the short- and long-term effectiveness of intensive short-term dynamic psychotherapy (ISTDP) in the treatment of patients with the Diagnostic and Statistical Manual of Mental Disorder, IV edition - Text Revision anxiety disorders, as provided by novice psychology trainees. Twenty-two patients with anxiety disorders were provided ISTDP. Patients improved significantly on all outcome indices, including the global assessment of functioning, the symptom checklist and the inventory of interpersonal problems, at the end of the treatment and at 6 and 12 month follow-up. In addition to these results, there was marked structural personality change as evidenced by ratings on the Shedler Westen assessment procedure (SWAP-200), at the same assessment moments; the SWAP-200 psychological health index score showed a meaningful increase in adaptive psychological resources and capacities, while the mean number of personality diagnoses decreased from the beginning to the end of therapy, and all patients maintaining their gains in 6-12 month follow-up. We conclude that ISTDP provided by novice psychotherapists is efficacious in bringing broad and in-depth change to pathology that can perpetuate anxiety disorders and other psychiatric conditions. ©Copyright: the Author(s).Entities:
Keywords: Intensive short-term dynamic psychotherapy; anxiety disorders; outcome; trainees
Year: 2021 PMID: 33937111 PMCID: PMC8082537 DOI: 10.4081/ripppo.2021.503
Source DB: PubMed Journal: Res Psychother ISSN: 2239-8031
Analysis of pre-post and follow-up data.
| Measure | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | F value | Partial η2 |
|---|---|---|---|---|---|---|
| T1 | T2 | T3 | T4 | (dftime, dferror) | ||
| GAF | 55.28 (4.21) | 80.11 (5.57)* | 80.56 (4.89)* | 78.89 (4.73)* | 213.76** (1.956, 33.249) | 0.93 |
| SCL-ANX | 2.03 (.68) | 0.42 (0.31)* | 0.37 (0.27)* | 0.30 (0.18)* | 90.12** (1.260, 21.415) | 0.84 |
| SCL-GSI | 1.51 (.43) | 0.28 (0.17)* | 102.64** (1.343, 22.824) | 0.86 | ||
| IIP-32 | 59.17 (8.42) | 49.33 (5.43)* | 46.33 (5.38)* | 45.78 (5.39)* | 27.35** (1.746, 29.682) | 0.62 |
| SWAP-PHI | 54.24 (7.52) | 64.69 (4.01)* | 66.01 (4.43)* | 64.79 (4.28)* | 48.96** (1.395, 23.714) | 0.74 |
SD, standard deviation; T1, beginning of therapy; T2, end of therapy; T3, 6 months follow-up; T4, 12 months follow-up; GAF, global assessment of functioning; SCL-ANX, anxiety scale of the SCL-90-R; SCL-GSI, global severity index of the SCL-90R; IIP-32, inventory of interpersonal problems; SWAP-PHI, psychological health index of the SWAP-200. *P<0.05; there was a statistically significant decrease from T1 to T2, from T1 to T3, and from T1 to T4 on all measures, but not from T2 to T3 and T3 to T4 (Post hoc tests using the Bonferroni correction); **P<0.001; one-way repeated measures ANOVAs with a Greenhouse-Geisser correction indicated statistically significant differences on outcome measures between T1, T2, T3 and T4.
Clinically significant change in anxiety symptoms.
| Criterion | SCL-ANX (T2; n=22)a | SCL-ANX (T3; n=18)a | SCL-ANX (T4; n=18)a |
|---|---|---|---|
| RCI>1.96b | 16 (73%) | 15 (83%) | 15 (83%) |
| Functional distributionc | 22 (100%) | 18 (100%) | 18 (100%) |
| Clinical significanced | 16 (73%) | 15 (83%) | 15 (83%) |
| Deterioratione | 0 (0%) | 0 (0%) | 0 (0%) |
SCL-ANX, anxiety scale of the SCL-90-R; T2, end of therapy; T3, follow-up 6 months; T4, follow-up 1 year; RCI, reliable change index. aAnxiety subscale of the symptom checklist; bnumber of individuals who reliably improved after adjusting pretest scores for regression to the mean; cnumber of individuals who fell within 2 standard deviations of the general population mean; dnumber of individuals who reliably improved and fell within 2 standard deviations of the general population mean; enumber of individuals who reliably deteriorated during treatment.
Mean number of dimensions with a value over cut-off per patient at the beginning, the end and at follow-up assessments.
| T1 (N=22) | T2 (N=22) | T3 (N=18) | T4 (N=18) | |||||
|---|---|---|---|---|---|---|---|---|
| >60 | >55 | >60 | >55 | >60 | >55 | >60 | >55 | |
| DSM personality disorders | 0.64 | 1.68 | 0.00 | 0.05 | 0 | 0.16 | 0.00 | 0.22 |
DSM, Diagnostic and Statistical Manual; T1, beginning of therapy; T2, end of therapy; T3, follow-up 6 months; T4, follow-up 1 year. Values >60 = categorical diagnoses; values >55 = traits.